Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Net Income (2023 - 2024)

Exozymes (EXOZ) has disclosed Net Income for 2 consecutive years, with -$1.8 million as the latest value for Q4 2024.

  • Quarterly Net Income fell 74.02% to -$1.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$5.9 million through Dec 2024, changed N/A year-over-year, with the annual reading at -$9.2 million for FY2025, 56.26% down from the prior year.
  • Net Income for Q4 2024 was -$1.8 million at Exozymes, down from -$1.7 million in the prior quarter.
  • The five-year high for Net Income was -$520596.0 in Q3 2023, with the low at -$1.8 million in Q4 2024.